BDBM17655 5-(5-chlorothiophen-2-yl)-N-[(3S)-1-[(2S)-1-(morpholin-4-yl)-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl]-4H-1,2,4-triazole-3-sulfonamide::N-[(3S)-2-oxopyrrolidin-3-yl]sulfonamide, 1x
SMILES: C[C@H](N1CC[C@H](NS(=O)(=O)c2nnc([nH]2)-c2ccc(Cl)s2)C1=O)C(=O)N1CCOCC1
InChI Key: InChIKey=FKCQUVAGEOSYRU-QWRGUYRKSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor X (Homo sapiens (Human)) | BDBM17655 (5-(5-chlorothiophen-2-yl)-N-[(3S)-1-[(2S)-1-(morph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | MMDB PC cid PC sid PDB UniChem | MMDB PDB Article PubMed | 534 | -8.46 | n/a | n/a | n/a | n/a | n/a | 7.4 | 22 |
GSK | Assay Description The ability of test compounds to inhibit human fXa in vitro was determined in a fluorescence assay using rhodamime 110, bis-(Boc-L-glycylglycyl-L-arg... | J Med Chem 50: 1546-57 (2007) Article DOI: 10.1021/jm060870c BindingDB Entry DOI: 10.7270/Q2F18X06 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) |